Pierre Fabre Laboratories and Iktos, a Artificial Intelligence (AI) and Robotics firm specializing in drug discovery, entered an integrated drug discovery collaboration to identify and develop novel small-molecule drug candidates in oncology. The alliance aims to advance oncology research by integrating computational design, medicinal chemistry, biology, medical science and preclinical development. Under the agreement, Iktos will leverage its AI-driven generative design platform to help advan...